knowledge -WSS

knowledge

author：hotspot 2025-09-29 23:03:46 - browse：7

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Case highlights the risks of experimental stem cell therapy

explore

WSS

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Abridge raises $150m as clinical notes automation market heats up

Readers respond to H5N1 and livestock movements, and more

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Arc Institute generative AI designs new CRISPR systems

Helping hospitals and community health centers plan for resilience

hotspot

knowledge

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Big Tobacco's 'harm reduction': Is it for real, or a sham?

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Data integrity in scientific journals requires "effort" by publishers, institutions

Heart attack and stroke risk calculators need revising

With measles on the rise, a personal story of a devastating disease

BioMarin wins approval for gene therapy to treat hemophilia A

Congress may force more Covid

hotspot

Wearables generate powerful data but its not useful to doctors, yet

Surprise medical billing ban raises prices elsewhere

Solving academic medical centers' existential crisis

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Second House panel advances two

leisure time

entertainment

explore

Wikipedia